Advicenne: Advicenne Announces 2024 Gross Sales1
2024 Gross sales reported at €4.8 million, up 9.2%. Gross sales of Sibnayal® (potassium citrate potassium bicarbonate) in France recorded an impressive 40% growth. Royalties for 2024 are estimated...
Read full article »
Advicenne is a biopharmaceutical company that develops and commercializes tubular acidosis therapeutics for the treatment of kidney diseases.
Read more